Yuyu Pharma Inc

000227 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

7,470.00KRW-710.00 (-8.68%)

Price History

Full chart

Market Stats

Previous Close8,180.00

Open8,210.00

Day Range7,470.00 – 8,210.00

52-Week Range5,810.00 – 12,267.18

Volume4.04K

Market Cap39.40B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield1.63%

Beta0.41

50-Day Avg7,441.40

200-Day Avg9,748.50

About

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Wonsang Yu
Employees243
Headquarters94 Biovalley 1-ro, Jecheon-si, South Korea, 27159, Korea
Websitehttps://www.yuyu.co.kr

Leadership

Mr. Wonsang YuCEO & Director · b. 1974
NoYong ParkCEO & Inside Director

Financials

Income Statement

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	62.82B	69.74B	71.58B	62.85B	83.10B	90.88B	98.12B	115.66B	138.88B	137.21B	133.15B	140.88B
Growth (%)	-	+11.03%	+2.63%	-12.19%	+32.21%	+9.36%	+7.97%	+17.87%	+20.08%	-1.20%	-2.96%	+5.81%
Cost of Revenue	31.81B	38.96B	38.21B	32.87B	42.46B	44.27B	52.85B	70.32B	85.57B	88.31B	81.44B	86.94B
Gross Profit	31.01B	30.78B	33.37B	29.99B	40.64B	46.61B	45.27B	45.34B	53.31B	48.90B	51.70B	53.94B
Gross Margin	49.36%	44.13%	46.62%	47.71%	48.90%	51.29%	46.14%	39.20%	38.39%	35.64%	38.83%	38.29%
Operating Expense	29.64B	29.17B	29.64B	26.42B	35.31B	38.54B	39.00B	44.14B	53.91B	48.53B	39.12B	42.92B
Operating Income	1.37B	1.61B	3.73B	3.57B	5.33B	8.07B	6.27B	1.20B	-592.11M	364.54M	12.58B	11.02B
Operating Margin	2.18%	2.31%	5.22%	5.68%	6.41%	8.89%	6.39%	1.04%	-0.43%	0.27%	9.45%	7.82%
EBITDA	-	-	-	6.66B	7.90B	11.51B	9.37B	6.30B	3.80B	2.72B	18.87B	17.57B
EBITDA Margin	-	-	-	10.59%	9.50%	12.66%	9.55%	5.44%	2.73%	1.98%	14.17%	12.47%
Net Income	-7.47B	-252.68M	5.89B	4.54B	4.02B	4.72B	1.28B	-2.21B	-5.99B	-7.18B	8.72B	8.15B
Net Income Margin	-11.89%	-0.36%	8.22%	7.23%	4.84%	5.20%	1.31%	-1.91%	-4.31%	-5.23%	6.55%	5.79%
R&D	1.13B	1.25B	2.25B	1.69B	1.42B	876.67M	4.12B	4.01B	8.62B	7.19B	2.78B	3.61B
R&D as % of Total Revenue	1.80%	1.79%	3.14%	2.69%	1.71%	0.96%	4.20%	3.47%	6.21%	5.24%	2.09%	2.56%
Interest Expense	0	0	0	0	1.12B	1.79B	1.76B	2.18B	2.58B	2.55B	3.22B	2.48B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	1.35%	1.97%	1.79%	1.88%	1.86%	1.86%	2.42%	1.76%

Balance Sheet

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	101.40B	104.33B	111.30B	121.49B	135.23B	137.72B	154.90B	192.99B	195.21B	198.21B	207.69B	207.22B
Total Liabilities	29.91B	30.60B	33.01B	38.66B	48.35B	47.17B	37.86B	64.30B	71.83B	77.86B	72.62B	66.68B
Total Equity	69.12B	71.56B	77.16B	81.96B	85.79B	88.69B	114.36B	124.28B	116.82B	112.19B	125.23B	129.63B
Cash	11.12B	9.83B	18.91B	19.81B	26.97B	26.85B	20.32B	50.26B	25.84B	30.60B	41.83B	29.09B
Net Debt	-	-	-	-	244.28M	-	-	-	12.64B	7.97B	-	-

Cash Flow

Currency: KRW	2006-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	1.36B	-11.68B	9.82B	561.35M	6.11B	13.19B	-2.67B	4.51B	-6.23B	420.86M	24.95B	15.88B
Investing Cash Flow	-	2.87B	-3.53B	1.45B	-3.43B	-9.94B	-5.33B	-12.14B	-5.89B	-8.54B	-	-	-
Financing Cash Flow	-	-495.71M	13.94B	-2.20B	1.78B	10.95B	-8.04B	8.51B	31.31B	-9.08B	-	-	-
Capital Expenditure	0	404.37M	2.09B	2.32B	5.19B	9.76B	8.06B	12.05B	6.07B	5.28B	5.11B	7.30B	8.45B
Free Cash Flow	-	-	-	-	-3.20B	-3.96B	4.45B	-16.96B	-2.24B	-11.80B	-4.69B	17.65B	7.42B
Dividends Paid	-	1.07B	1.20B	1.27B	1.27B	1.38B	1.44B	1.52B	1.85B	2.03B	2.00B	-	1.93B
FCF to OCF	-	-	-	-	-569.80%	-64.81%	33.74%	635.38%	-49.73%	189.38%	-1113.29%	70.73%	46.75%
Dividend Paid to FCF	-	-	-	-	-39.83%	-34.95%	32.45%	-8.96%	-82.56%	-17.24%	-42.72%	-	25.99%

Key Statistics & Ratios

Market Cap39.40B

Enterprise Value135.11B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.28

Price / Book0.00

Revenue (TTM)144.37B

Gross Profit (TTM)55.69B

EBITDA18.81B

Profit Margin8.66%

Operating Margin10.91%

Return on Equity8.85%

Return on Assets4.02%

Shares Outstanding5.86M

Shares Float10.09M

Beta0.41

Dividend Yield1.63%

Dividend Rate125.00

Payout Ratio0.00%

Dividends

20251×

125.00Dec 29, 2025

20241×

120.00Dec 27, 2024

20221×

110.00Dec 28, 2022

20211×

110.00Dec 29, 2021

20201×

110.00Dec 29, 2020

20191×

110.00Dec 27, 2019

20181×

105.00Dec 27, 2018

20172×

100.00Dec 27, 201795.00Mar 30, 2017

20161×

95.00Mar 30, 2016

20151×

95.00Mar 30, 2015

20141×

95.00Mar 28, 2014

20131×

85.00Mar 28, 2013

20121×

65.00Mar 29, 2012

20111×

55.00Mar 30, 2011

20101×

50.00Mar 30, 2010

20091×

45.00Mar 30, 2009

20081×

155.00Mar 28, 2008

20061×

115.00Mar 30, 2006

20051×

110.00Mar 30, 2005

20041×

105.00Mar 30, 2004

20021×

85.00Mar 28, 2002

20011×

15.00Mar 29, 2001

Stock Splits

Mar 30, 20212:1
Feb 6, 20065:1